Ayurcann Holdings Corp.
AYURF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8 | $5 | $5 | $5 |
| - Cash | $1 | $2 | $1 | $1 |
| + Debt | $1 | $1 | $3 | $1 |
| Enterprise Value | $8 | $4 | $7 | $4 |
| Revenue | $6 | $8 | $8 | $8 |
| % Growth | -21.4% | 2.5% | 0.7% | – |
| Gross Profit | $2 | $2 | $3 | $3 |
| % Margin | 25.3% | 19.4% | 34.1% | 43.6% |
| EBITDA | -$1 | -$2 | -$0 | $0 |
| % Margin | -9.3% | -29.3% | -2.7% | 4.2% |
| Net Income | -$1 | -$2 | -$1 | -$0 |
| % Margin | -13% | -24.7% | -7.4% | -1.6% |
| EPS Diluted | -0.004 | -0.01 | -0.003 | -0.001 |
| % Growth | 58.2% | -237.9% | -383.3% | – |
| Operating Cash Flow | -$1 | $1 | $0 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | $1 | $0 | $1 |